Evaluation of portal MR angiography using superparamagnetic iron oxide

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 1, 1997, Pages 191-196

  Knollmann, F D ^b   Bock J C ^b   Teltenkotter S ^b   Wlodarczyk, W ^b   Muhler A ^a   Vogl, Th J ^b   Felix, R ^b  

^a BAYER PHARMA AG   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Contrast agents; Liver disease; MR angiography; MR imaging; Portal vein; SHU 555A

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DOSE RESPONSE; IMAGE ANALYSIS; LIVER DISEASE; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; SIGNAL NOISE RATIO; SWINE;

ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EVALUATION STUDIES; FERRIC COMPOUNDS; IMAGE ENHANCEMENT; INJECTIONS, INTRAVENOUS; LIVER; MAGNETIC RESONANCE ANGIOGRAPHY; PORTAL VEIN; ROC CURVE; SENSITIVITY AND SPECIFICITY; SWINE; SWINE, MINIATURE;

EID: 0031421904     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070129     Document Type: Article

References (22)

1. Davis PL, Van Thiel DH, Zajko AB, Campbell WL, Sumkin JH, Rothschild MA. Imaging in hepatic transplantation. Sem Liv Disease 1989; 9:90-101.
2. Finn JP, Edelman RR, Jenkins RL, et al. Liver transplantation: MR angiography with surgical validation. Radiology 1991; 179: 265-269.
3. Marchal G, Bosmans H, McLachlan SJ. Magnetopharmaceuticals as contrast agents. In: Potchen EJ, Haacke EM, Siebert JE, Gottschalk A, eds. Magnetic resonance angiography: concepts and applications. St. Louis: Mosby, 1993; 305-322.
4. Ward J, Martinez D, Chalmers AG, Ridgway J, Robinson PJ, Smith MA. Rapid dynamic contrast-enhanced magnetic resonance imaging of the liver and portal vein. Br J Radiol 1993; 66: 214-222.
5. Böck JC, Pison U, Kaufmann F, Felix R. Gd-DTPA-polylysine-enhanced pulmonary time-of-flight MR angiography. J Magn Reson Imaging 1994; 4:473-476.
6. Vogl TJ, Hammerstingl R, Pegios W, et al. The value of liver-specific superparamagnetic contrast medium AMI-25 for the detection and differential diagnosis of primary liver tumors versus metastasis. Fortschr Geb Rontgenstrahlen Neuen Bildgeb Verfahr Erganzungsbd 1994; 160:319-328.
7. Hagspiel KD, Neidl KFW, Eichenberger AC, Weder W, Marincel B. Detection of liver metastasis: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995; 196:471-478.
8. Ros PR, Freeny PC, Harms SE, et al. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995; 196: 481-488.
9. Bellin MF, Zaim S, Auberton E, et al. Liver metastasis: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 1994; 193:657-663.
10. Denys A, Arrive L, Servois V, et al. Hepatic tumors: detection and characterization at 1 T MR imaging enhanced with AMI-25. Radiology 1994; 193:665-669.
11. Chambon C, Clement O, LeBlanche A, Schouman-Clays E, Frija G. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. Magn Reson Imaging 1993; 11:509-519.
12. Frank H, Weissleder R, Brady TJ. Enhancement of MR angiography with iron oxides: preliminary studies in whole-blood phantom and in animals. AJR Am J Roentgenol 1994; 162:209-211.
13. Brown DG, Riederer SJ. Contrast-to-noise ratios in maximum intensity projection images. Magn Reson Med 1992; 23:130-137.
14. Metz CE. ROC methodology in radiologic imaging. Invest Radiol 1986; 21:720-733.
15. Weissleder R. Liver MR imaging with iron oxides: toward consensus and clinical practice. Radiology 1994; 193:593-595.
16. Hamm B, Staks T, Taupitz M. SHU 555A a new superparamagnetic iron oxide contrast agent for magnetic resonance imaging. Invest Radiol 1994; 29:S87-89.
17. Saini S, Edelmann RR, Sharma P, et al. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial experience with ultrasmall superparamagnetic iron oxide (AMI-227). AJR Am J Roentgenol 1995; 164:1147-1152.
18. Bulte JWM, Vymazal J, Brooks RA, Pierpaoli C, Frank JA. Frequency dependence of MR relaxation times: II. iron oxides. J Magn Reson Imaging 1993; 3:641-648.
19. Ferris JV, Marsh JW, Little AF. Presurgical evaluation of the liver transplant candidate. Radiol Clin North Am 1995; 33:497-520.
20. Finn JP, Siewert B, Müller M. Portal magnetic resonance angiography. MRI Clin North Am 1993; 1:271-280.
21. Burkart DJ, Johnson CD, Morton MJ, Ehman RL: Phase-contrast cine MR angiography in chronic liver disease. Radiology 1993; 187:407-412.
22. Mitchell DG, Stark DD, Hahn PF: Breath-hold techniques. In: Mitchell DG, Stark DD, Hahn PF, eds. Hepatobiliary MRI. St. Louis: Mosby Year Book, 1992; 15.